Featured Speakers + 2024 Agenda

About the 2024 Conference

September 12 + 13, 2024, Colorado BioScience Association will host the highly anticipated Rocky Mountain Life Sciences Investor & Partnering Conference.

High-profile angel investors, venture capitalists, and representatives from large life sciences companies converge in the Colorado mountains to learn about new breakthroughs coming out of the Rocky Mountain Region from emerging life sciences companies in biotech, pharma, medical device, diagnostic, ag bio, and animal health.

The event reinforces CBSA’s commitment to Capital + Growth, supporting access to capital at all stages of development, and commercialization for life sciences companies.

Conference Opportunities

• Connect with investors and health innovators.
  Explore networking and one-on-one partnering opportunities.
• Discover leading-edge innovations in medical device, diagnostics, biotech and pharmaceuticals, ag bio and animal health, and digital health.
• Hear from nationally recognized speakers and panelists sharing key life sciences trends.
• Enjoy the relaxed mountain setting while sourcing opportunities and building partnerships.
• New, larger location in Breckenridge to accommodate demand—the 2022 event was standing room only.

Featured Speakers + Agenda

Thursday, September 12, 2024

11:00 a.m. – 11:30 a.m.

Registration

11:30 a.m. – 1:30 p.m.

Lunch Keynote - Siri Lindley

We’re honored to welcome Siri Lindley, world champion triathlete, business performance coach, former resident of Boulder, and one of Tony Robbins’ top motivational speakers, who credits a clinical trial at CU Anschutz for saving her life, as our opening day keynote speaker at the Rocky Mountain Life Sciences Investor & Partnering Conference.

Siri’s journey from novice swimmer to world-renowned triathlete, coach, and motivational speaker showcases her resilience and passion for transforming lives. Siri’s determination led her to dominate the triathlon world, winning prestigious championships and mentoring top athletes. Even in the face of an Acute Myeloid Leukemia diagnosis in 2019, Siri emerged victorious, becoming cancer-free by 2020.

In Colorado’s health innovation community, Siri found support during her battle with leukemia, collaborating with UCHealth and participating in a medical trial at the Anschutz Medical Campus. She advocates for equitable access to medical trials, aiming to ensure all patients have access to cutting-edge treatments.

Her journey showcases the intersection of personal resilience and the transformative power of Colorado’s life sciences ecosystem, offering hope and healing to those facing life-threatening illnesses. Through her work, Siri provides tools and encouragement for others to overcome obstacles and live fearlessly.

SPONSORS

1:45 p.m. – 3:00 p.m. 

Company Presentations

Track 1: 

1:45 p.m. - Ambrosia Biosciences

2:05 p.m. - Illumen Therapeutics, Inc.

2:25 p.m. - Photon Pharma

Track 2:

1:45 p.m. - Vega Surgical Systems

2:05 p.m. - EnteroTrack LLC

2:25 p.m. - Eye to Eye Telehealth

2:45 p.m. - Green Sun Medical

Track 3: 

1:45 p.m. - Enveda Biosciences

2:05 p.m. - TrAMPoline Pharma, Inc.

2:25 p.m. - Vona Oncology

2:45 p.m. - Onconaut Therapeutics Inc.

TRACK SPONSORS

3:00 p.m. – 3:45 p.m.

Partnering + Coffee Break 

Networking sessions scheduled throughout the day allow time for group conversations and one-on-one meetings. Be sure to download our app to facilitate partnering before, during and after the conference.

SPONSORS

3:45 p.m. – 5:20 p.m. 

Company Presentations

Track 1: 

3:45 p.m. - NuvOx Therapeutics Inc.

4:05 p.m. - Reglagene

4:25 p.m. - RheumaGen

4:45 p.m. - SiVEC Biotechnologies, Inc.

5:05 p.m. - Codebreaker Tx

Track 2:

3:45 p.m. - illumifyDx, Inc.

4:05 p.m. - Lazzaro Medical, Inc.

4:25 p.m. - TissueForm

4:45 p.m. - Aspero Medical

5:05 p.m. - GelSana

Track 3: 

3:45 p.m. - Umoja Biopharma

4:05 p.m. -  Think Bioscience

4:25 p.m. - Elysium Therapeutics

4:45 p.m. - STAQ Pharma

TRACK SPONSORS

5:20 p.m. – 6:30 p.m. 

Welcome Cocktail Reception 

SPONSORS

Friday, September 13, 2024

7:30 a.m. – 9:30 a.m.

Breakfast Keynote Panel: Emerging Investment Trends to Propel Life-Saving Innovations

We welcome a distinguished lineup of thought leaders to discuss emerging investment trends and areas of interest fueling life-saving health innovations, including market & deal-making, emerging technologies, underinvested populations, and future opportunities.

Eric. J. Dimise, Ph.D.
Sector Lead, Healthcare and Life Sciences Capital Markets, New York Stock Exchange

Eric Dimise, PhD, is Sector Lead, Healthcare & Life Sciences Capital Markets NYSE Group, a part of Intercontinental Exchange, Inc. (NYSE: ICE). Eric is responsible for attracting new listings from companies within the healthcare and life sciences industry. He advises companies, private equity and venture capital firms, investment bankers, and other key stakeholders on the IPO landscape, NYSE initiatives, and listing venue selection.

Prior to NYSE, Eric served as Vice President of Healthcare Content and Events at Gerson Lehrman Group (GLG) and before GLG as a Cardiovascular and Metabolic Disease Analyst at GlobalData. He completed his doctoral training in Chemistry at Boston College and a postdoctoral research fellowship at Harvard Medical School.

The New York Stock Exchange is the world's largest stock exchange, with a combined market capitalization of $39 trillion and an unmatched community of leading companies. It is the premier global venue for capital raising and is part of Intercontinental Exchange (NYSE: ICE), a leading global provider of technology and data.

Jay Freeberg
Chief Financial Officer, Oncology Ventures

Jay Freeberg is the CFO of Oncology Ventures, a venture capital firm focused on investing in healthcare data startups that enhance cancer care and research.  Jay is a partner emeritus of a New York-based accounting firm, where he was a partner for 24 years.  Jay has also run a financial planning and investment management firm since 1986 and is currently with Onyx Bridge Wealth Group LLC.  

Jay also advises on business transactions (mergers, buyouts and capital raises), and had served on the executive board for INAA, the International Association of Independent Accounting Firms.  He is the Former Chairman of the Personal Financial Planning Committee for the New York State Society of CPAs.  

He has been a judge for the annual NYU Entrepreneurs Challenge Business Plan Competition for the past 20 years.  One of the companies that he judged, and put through to the finals, was called Tote.  They have since pivoted and are now called Pinterest. 

Jay will be running his fifth NYC Marathon this November and ran one NYC Triathlon; he also enjoys skiing, pickleball and hiking.

Marc Graboyes
Counsel, Foley Hoag

Marc Graboyes is a corporate attorney in the Denver office of Foley Hoag, where he represents emerging growth companies and the investors that support them, with a primary focus on the life sciences industry.

Mr. Graboyes has nearly 30 years of experience as a senior executive and corporate attorney during which time he has helped raise over $1B in public and private equity and debt financings, completed dozens of public and private mergers and acquisitions, served as in-house general counsel of a Nasdaq-listed biotechnology company with fully integrated drug development and commercial operations, as well as co-founder and CEO of one of Colorado’s first cannabis biotech companies.

By leveraging this experience, Marc brings a unique blend of entrepreneurial savvy and business acumen to the representation of his clients, helping them navigate complex legal challenges and achieve their strategic growth objectives.

Abby Mueller
Investor, J.P. Morgan Life Sciences Private Capital 

Abby joined J.P. Morgan Life Sciences Private Capital in 2023. Prior to joining LSPC, Abby was on the Strategy and Business Development team at SpringWorks Therapeutics, expanding the company’s preclinical and clinical portfolio. Abby began her career as an investment banker at Bank of America Merrill Lynch where she completed M&A and equity transactions for smid-cap biotech companies. Abby graduated from the University of North Carolina at Chapel Hill where she studied Chemistry and Business Administration.

J.P. Morgan Life Sciences Private Capital closed its inaugural fund in 2024. The Fund invests in private biotechnology companies across stage, modality, therapeutic area, and geography. The Fund’s early company formation activities and portfolio investments span cardiometabolic disease, oncology, immunology, and genetic medicines. The Fund also aims to leverage the scale and resources of J.P. Morgan to add value to portfolio companies.

Kimberly Muller, M.Sc., J.D.
General Partner, CU Healthcare Innovation Fund & Executive Director, CU Innovations

Kimberly Muller is the executive director of CU Innovations where she leads innovation for the University of Colorado Anschutz Medical Campus. Her business development responsibilities include investing, company creation, innovation management, forming key strategic industry partnerships, and licensing. Large-scale industry collaborations have been established in areas such as AI and drug development. Muller also manages several investment funds, including a $10 million innovation grant fund, a $50 million early-stage venture fund, a $75 million follow-on fund, and partners with UCHealth on a $100 million growth-stage fund. Muller has a graduate degree in Genetics and received her law degree with highest honors from the University of Connecticut School of Law.

SPONSOR

New fund launched by cancer survivor to invest in and empower data-driven startups improving cancer care and research.

J.P. Morgan Life Sciences Private Capital Inaugural $500M biotechnology venture capital fund launched in 2024 to support highly innovative companies across stage, modality, therapeutic area, and geography while leveraging the scale of J.P. Morgan to add value to portfolio companies.

A strategic healthcare fund affiliated with the University of Colorado Anschutz Medical Campus making strategic investments in ventures across the healthcare spectrum to fuel innovation ecosystem collaborations to clinically validate and co-develop novel healthcare solutions.

9:45 a.m. – 11:00 a.m.

Company Presentations

Track 1: 

9:45 a.m. - myUTI, Inc.

10:05 a.m. - Emet Surgical

10:25 a.m. - NowVitals

10:45 a.m. - PFRx, Inc.

Track 2:

9:45 a.m. - Darwin Biosciences

10:05 a.m. - AOA Dx

10:25 a.m. - Burst Diagnostics

10:45 a.m. - Biodesix, Inc.

Track 3: 

9:45 a.m. - ARPA-H NITRO Program to Cure Osteoarthritis (CU)

10:05 a.m. - Ajna BioSciences PBC

10:25 a.m. - Arpeggio Biosciences

11:00 a.m. – 11:45 a.m.

Partnering + Coffee Break 

Networking sessions scheduled throughout the day allow time for group conversations and one-on-one meetings. Be sure to download our app to facilitate partnering before, during and after the conference.

SPONSORS

ADDITIONAL SPONSORS